SIMPLEX TRADING, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6
-90.8%
3,788
-83.7%
0.00%
Q2 2023$65
+400.0%
23,189
+735.0%
0.00%
Q1 2023$13
+18.2%
2,777
+164.5%
0.00%
Q4 2022$11
-100.0%
1,050
-88.7%
0.00%
Q3 2022$86,000
+28.4%
9,252
+24.9%
0.00%
Q2 2022$67,000
+857.1%
7,407
+1172.7%
0.00%
Q1 2022$7,000
-87.0%
582
-87.0%
0.00%
Q4 2021$54,000
-63.8%
4,477
-35.2%
0.00%
Q1 2021$149,000
-64.1%
6,906
-74.8%
0.00%
-100.0%
Q4 2020$415,000
+310.9%
27,453
+244.4%
0.00%
Q3 2020$101,000
-55.3%
7,972
-39.7%
0.00%
Q2 2020$226,000
+105.5%
13,228
+57.9%
0.00%
Q1 2020$110,000
-18.5%
8,380
-0.3%
0.00%
Q4 2019$135,000
+11.6%
8,407
+26.6%
0.00%
Q3 2019$121,000
+1110.0%
6,641
+1092.3%
0.00%
Q1 2019$10,000
-94.8%
557
-96.3%
0.00%
-100.0%
Q4 2018$194,000
-56.6%
14,946
-20.0%
0.00%0.0%
Q3 2018$447,000
+190.3%
18,694
+47.7%
0.00%
-85.7%
Q4 2017$154,000
+2980.0%
12,654
+3047.8%
0.01%
Q3 2017$5,000
-95.8%
402
-94.8%
0.00%
-100.0%
Q2 2017$119,000
+230.6%
7,750
+292.0%
0.01%
+150.0%
Q1 2017$36,000
+28.6%
1,977
-34.4%
0.00%0.0%
Q4 2016$28,000
-33.3%
3,016
-55.9%
0.00%
-33.3%
Q1 2016$42,0006,8350.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders